214 related articles for article (PubMed ID: 15313374)
1. Comparative assessment of intimal hyperplasia development after 14 days in two different experimental settings: tissue culture versus ex vivo continuous perfusion of human saphenous vein.
Rey J; Probst H; Mazzolai L; Bosman FT; Pusztaszeri M; Stergiopulos N; Ris HB; Hayoz D; Saucy F; Corpataux JM
J Surg Res; 2004 Sep; 121(1):42-9. PubMed ID: 15313374
[TBL] [Abstract][Full Text] [Related]
2. Role of hemodynamic forces in the ex vivo arterialization of human saphenous veins.
Berard X; Déglise S; Alonso F; Saucy F; Meda P; Bordenave L; Corpataux JM; Haefliger JA
J Vasc Surg; 2013 May; 57(5):1371-82. PubMed ID: 23351647
[TBL] [Abstract][Full Text] [Related]
3. Comparison of morphological and functional alterations of human saphenous veins after seven and fourteen days of ex vivo perfusion.
Paroz A; Probst H; Saucy F; Mazzolai L; Rizzo E; Ris HB; Corpataux JM
Eur Surg Res; 2004; 36(5):274-81. PubMed ID: 15359090
[TBL] [Abstract][Full Text] [Related]
4. Ex vivo pulsatile perfusion of human saphenous veins induces intimal hyperplasia and increased levels of the plasminogen activator inhibitor 1.
Saucy F; Probst H; Alonso F; Bérard X; Déglise S; Dunoyer-Geindre S; Mazzolai L; Kruithof E; Haefliger JA; Corpataux JM
Eur Surg Res; 2010; 45(1):50-9. PubMed ID: 20798546
[TBL] [Abstract][Full Text] [Related]
5. Increased connexin43 expression in human saphenous veins in culture is associated with intimal hyperplasia.
Déglise S; Martin D; Probst H; Saucy F; Hayoz D; Waeber G; Nicod P; Ris HB; Corpataux JM; Haefliger JA
J Vasc Surg; 2005 Jun; 41(6):1043-52. PubMed ID: 15944608
[TBL] [Abstract][Full Text] [Related]
6. The development of an in vitro flow model of human saphenous vein graft intimal hyperplasia.
Porter KE; Nydahl S; Dunlop P; Varty K; Thrush AJ; London NJ
Cardiovasc Res; 1996 Apr; 31(4):607-14. PubMed ID: 8689653
[TBL] [Abstract][Full Text] [Related]
7. Shear stress and pressure modulate saphenous vein remodeling ex vivo.
Gusic RJ; Myung R; Petko M; Gaynor JW; Gooch KJ
J Biomech; 2005 Sep; 38(9):1760-9. PubMed ID: 16023463
[TBL] [Abstract][Full Text] [Related]
8. Modulation of phosphatidylinositol 3-kinase signaling reduces intimal hyperplasia in aortocoronary saphenous vein grafts.
Hata JA; Petrofski JA; Schroder JN; Williams ML; Timberlake SH; Pippen A; Corwin MT; Solan AK; Jakoi A; Gehrig TR; Kontos CD; Milano CA
J Thorac Cardiovasc Surg; 2005 Jun; 129(6):1405-13. PubMed ID: 15942585
[TBL] [Abstract][Full Text] [Related]
9. Vascular-wall remodeling of 3 human bypass vessels: organ culture and smooth muscle cell properties.
Mekontso-Dessap A; Kirsch M; Guignambert C; Zadigue P; Adnot S; Loisance D; Eddahibi S
J Thorac Cardiovasc Surg; 2006 Mar; 131(3):651-8. PubMed ID: 16515919
[TBL] [Abstract][Full Text] [Related]
10. Anti-MCP-1 gene therapy inhibits vascular smooth muscle cells proliferation and attenuates vein graft thickening both in vitro and in vivo.
Schepers A; Eefting D; Bonta PI; Grimbergen JM; de Vries MR; van Weel V; de Vries CJ; Egashira K; van Bockel JH; Quax PH
Arterioscler Thromb Vasc Biol; 2006 Sep; 26(9):2063-9. PubMed ID: 16825596
[TBL] [Abstract][Full Text] [Related]
11. A Gbetagamma inhibitor reduces intimal hyperplasia in aortocoronary saphenous vein grafts.
Petrofski JA; Hata JA; Williams ML; Parsa CJ; Thompson RB; Hanish SI; Gehrig TR; Koch WJ; Milano CA
J Thorac Cardiovasc Surg; 2005 Dec; 130(6):1683-90. PubMed ID: 16308016
[TBL] [Abstract][Full Text] [Related]
12. Shear force regulates matrix metalloproteinase activity in human saphenous vein organ culture.
Patterson MA; Leville CD; Hower CD; Jean-Claude JM; Seabrook GR; Towne JB; Cambria RA
J Surg Res; 2001 Jan; 95(1):67-72. PubMed ID: 11120638
[TBL] [Abstract][Full Text] [Related]
13. Paclitaxel treatment reduces neointimal hyperplasia in cultured human saphenous veins.
Schachner T; Steger C; Heiss S; Bonaros N; Sterlacci W; Laufer G; Bonatti J
Eur J Cardiothorac Surg; 2007 Dec; 32(6):906-11. PubMed ID: 17923411
[TBL] [Abstract][Full Text] [Related]
14. Validation of an in vitro model of human saphenous vein hyperplasia.
Castronuovo JJ; Smith TJ; Price RM
J Vasc Surg; 2002 Jan; 35(1):152-7. PubMed ID: 11802147
[TBL] [Abstract][Full Text] [Related]
15. A comparison of six statins on the development of intimal hyperplasia in a human vein culture model.
Corpataux JM; Naik J; Porter KE; London NJ
Eur J Vasc Endovasc Surg; 2005 Feb; 29(2):177-81. PubMed ID: 15649726
[TBL] [Abstract][Full Text] [Related]
16. Nitric oxide treatment reduces neo-intimal formation and modulates osteopontin expression in an ex-vivo human model of intimal hyperplasia.
Colotti C; Vittorini S; Ottaviano V; Maltinti M; Angeli V; Del Ry S; Giannessi D
Cytokine; 2009 May; 46(2):228-35. PubMed ID: 19285424
[TBL] [Abstract][Full Text] [Related]
17. Production and inhibition of the gelatinolytic matrix metalloproteinases in a human model of vein graft stenosis.
Porter KE; Thompson MM; Loftus IM; McDermott E; Jones L; Crowther M; Bell PR; London NJ
Eur J Vasc Endovasc Surg; 1999 May; 17(5):404-12. PubMed ID: 10329524
[TBL] [Abstract][Full Text] [Related]
18. Intimal hyperplasia and expression of transforming growth factor-beta1 in saphenous veins and internal mammary arteries before coronary artery surgery.
Friedl R; Li J; Schumacher B; Hanke H; Waltenberger J; Hannekum A; Stracke S
Ann Thorac Surg; 2004 Oct; 78(4):1312-8. PubMed ID: 15464491
[TBL] [Abstract][Full Text] [Related]
19. A new perfusion culture system used to study human vein.
Surowiec SM; Conklin BS; Li JS; Lin PH; Weiss VJ; Lumsden AB; Chen C
J Surg Res; 2000 Jan; 88(1):34-41. PubMed ID: 10644464
[TBL] [Abstract][Full Text] [Related]
20. Mutual exclusion of apoptosis and hsp70 in human vein intimal hyperplasia in vitro.
Alcocer F; Whitley D; Salazar J; Jordan W; Bland KI
J Surg Res; 2001 Mar; 96(1):75-80. PubMed ID: 11180999
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
